Deltanoid Pharmaceuticals develops treatments for renal disease, osteoporosis, skin disease and other targets. Deltanoid was founded in 1999. Deltanoid's headquarters is located in Madison, Wisconsin, USA 53719.
Deltanoid's CEO, Loreen Mershimer, cu...
Deltanoid's CEO, Loreen Mershimer, currently has an approval
rating of 70%. Deltanoid's primary competitors are
There are no competitors identified for Deltanoid
There have been no acquisitions found related to Deltanoid
Funding data cannot be found related to Deltanoid
Recent investment data cannot be found related to Deltanoid